chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise, Pain, Pain in extremity
Clinical narrative: Arm soreness; headache; body aches; low fever; general fatigue; feeling of illness; This is a spontaneous report from a contactable healthcare professional (patient). This 38-year-old female patient received dose 2 of BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE) on 23Feb2021 at 14:00 (at the age of 38-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included psoriatic arthritis and hidradenitis suppurativa. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications included spironolactone (ALDACTONE) and women's multivitamin from unknown dates for unknown indications. The patient previously received dose 1 of BNT162B2 on 27Jan2021 at 14:30 as a single dose in the left arm for COVID-19 immunization. The patient did not have any allergies to medications, food, or other products. On 23Feb2021 at 23:30 the patient experienced "same as generally expected," arm soreness, headache, body aches, low fever, general fatigue, and feeling of illness. The event were reported as non-serious. The patient was not hospitalized for the events. The patient did not receive any treatment for the events. The outcomes of arm soreness, headache, body aches, low fever, general fatigue, and feeling of illness were recovering. It was also reported that since the vaccine the patient had not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Arm soreness; headache; body aches; low fever; general fatigue; feeling of illness; This is a spontaneous report from a contactable healthcare professional (patient). This 38-year-old female patient received dose 2 of BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE) on 23Feb2021 at 14:00 (at the age of 38-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included psoriatic arthritis and hidradenitis suppurativa. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications included spironolactone (ALDACTONE) and women's multivitamin from unknown dates for unknown indications. The patient previously received dose 1 of BNT162B2 on 27Jan2021 at 14:30 as a single dose in the left arm for COVID-19 immunization. The patient did not have any allergies to medications, food, or other products. On 23Feb2021 at 23:30 the patient experienced "same as generally expected," arm soreness, headache, body aches, low fever, general fatigue, and feeling of illness. The event were reported as non-serious. The patient was not hospitalized for the events. The patient did not receive any treatment for the events. The outcomes of arm soreness, headache, body aches, low fever, general fatigue, and feeling of illness were recovering. It was also reported that since the vaccine the patient had not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Dizziness, Headache, Nausea
Clinical narrative: slight headache; extremely dizzy; joints ached; nauseated; felt really weak; This is a spontaneous report from a contactable nurse (patient). This non-pregnant 69-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EN6202) via an unspecified route of administration in the left arm on 23Feb2021 at 07:30 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, COVID-19, tape allergy, and osteoarthritis all from unknown dates and unknown if ongoing. The patient reported taking concomitant medications. The patient previously received nubain for an unknown indication and experienced allergy, codeine for an unknown indication and experienced allergy, oseltamivir phosphate (TAMIFLU) for an unknown indication and experienced allergy, and amoxicillin sodium; clavulanate potassium (AUGMENTIN) for an unknown indication and experienced allergy.The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 23Feb2021 after receiving her injection, she went home and in a little while she had a slight headache. She took a muscle relaxer and went to bed around 11:30. When the patient got up to go to the bathroom, she was extremely dizzy, her joints ached, she was nauseated and felt really weak. The events were reported as non-serious and did not require hospitalization. The clinical outcomes of slight headache, extremely dizzy, joints ached, nauseated and felt really weak were recovering. It was also reported that since vaccination the patient had not been tested for COVID-19.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Vaccination site pain
Clinical narrative: Metallic taste in mouth (though I was still able to taste food normally); Arm pain where I received the injection; This is a spontaneous report from a contactable Other Health Professional, the patient.  A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL3247), via an unspecified route of administration on 23Feb2021 at 13:45 (at the age of 37-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history included asthma. The patient has no allergies to medications, food or other products.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The vaccine was administered at a workplace clinic. Concomitant medication was reported as "No." The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Feb2021 the patient experienced arm pain where he received the injection and experienced a metallic taste in his mouth. He specified that he was still able to taste food normally. As treatment for the event vaccination site pain, the patient applied ice to his arm (reported as "iced my arm"). The clinical outcomes of the events vaccination site pain and metallic taste in mouth were reported as recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Somnolence
Clinical narrative: Metallic taste in mouth (though I was still able to taste food normally); Arm pain where I received the injection; This is a spontaneous report from a contactable Other Health Professional, the patient.  A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL3247), via an unspecified route of administration on 23Feb2021 at 13:45 (at the age of 37-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history included asthma. The patient has no allergies to medications, food or other products.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The vaccine was administered at a workplace clinic. Concomitant medication was reported as "No." The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Feb2021 the patient experienced arm pain where he received the injection and experienced a metallic taste in his mouth. He specified that he was still able to taste food normally. As treatment for the event vaccination site pain, the patient applied ice to his arm (reported as "iced my arm"). The clinical outcomes of the events vaccination site pain and metallic taste in mouth were reported as recovering. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia
Clinical narrative: fever; chills; This is a spontaneous report from a contactable consumer (patient). This 72-year-old male consumer received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EN6200) via an unspecified route of administration in the right arm on 18Feb2021 at 08:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food or other products, and was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included atorvastatin 10 mg, finasteride 5mg, and aspirin [acetylsalicylic acid] 81 mg, all from unknown dates for unknown indications. The patient previously received the first dose of BNT162B2 (lot number EL9262) in the left arm on 28Jan2021 at 14:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that on the night of the second injection, also reported as 19Feb2021 at 00:15, he developed fever and chills. The next morning, he had a fever of 101.4 and took 1300 mg of acetaminophen. The rest of the day his temperature averaged 99.7. The next morning his temperature was 97.7 and he felt much better. The events were reported as non-serious and did not require hospitalization. The clinical outcomes of fever and chills were recovered in Feb2021. It was also reported that since vaccination, the patient had not been tested for COVID-19.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Pain
Clinical narrative: Fever; chills; body aches; joint pain; headache; severe fatigue; This is a spontaneous report from a contactable nurse (the patient).  A non-pregnant 55-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201), via an unspecified route of administration, in the right arm on 22Feb2021 at 16:15 PM (at the age of 55 years) as a single dose for COVID-19 immunization. Medical history included hypertension. There was no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19 Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Historical vaccine included first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248), in the right arm on 28Jan2021 at 4:15 PM. On 23Feb2021, about 18 hours after vaccination, the patient experienced fever, chills, body aches, joint pain, headache, severe fatigue. Events reported as non-serious. No treatment was given for the events. The clinical outcome of  the events fever, chills, body aches, joint pain, headache, severe fatigue was recovered. . It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; chills; body aches; joint pain; headache; severe fatigue; This is a spontaneous report from a contactable nurse (the patient).  A non-pregnant 55-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201), via an unspecified route of administration, in the right arm on 22Feb2021 at 16:15 PM (at the age of 55 years) as a single dose for COVID-19 immunization. Medical history included hypertension. There was no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19 Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Historical vaccine included first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248), in the right arm on 28Jan2021 at 4:15 PM. On 23Feb2021, about 18 hours after vaccination, the patient experienced fever, chills, body aches, joint pain, headache, severe fatigue. Events reported as non-serious. No treatment was given for the events. The clinical outcome of  the events fever, chills, body aches, joint pain, headache, severe fatigue was recovered. . It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Aphthous ulcer, Ear discomfort, Ear pain, Headache, Pain in jaw
Clinical narrative: right ear irritation moving to ear pressure to ear pain behind ear lobe; right ear irritation moving to ear pressure to ear pain behind ear lobe; headache; right side of mouth canker sore; right side of head jaw pain; This is a spontaneous report from a contactable consumer (patient). This 55-year-old female patient received dose 2 of BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE; lot number EL9269) via an unspecified route on 11Feb2021 at 12:00 (at the age of 55-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included erratic blood pressure and Von Willebrand Syndrome. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications included levothyroxine and hydrochlorothiazide from unspecified dates for unspecified indications. The patient received dose 1 of BNT162B2 (lot number EL9261) on 20Jan2021 at 11:30 as a single dose in the left arm for COVID-10 immunization. The patient did not have any allergies to medications, food, or other products. On 19Feb2021 at 07:00 the patient experienced right ear irritation moving to ear pressure to ear pain behind ear lobe, right side of mouth canker sore, right side of head jaw pain, and headache. The patient visited a doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The outcomes of right ear irritation moving to ear pressure to ear pain behind ear lobe, right side of mouth canker sore, right side of head jaw pain, and headache were not recovered. It was also reported that since the vaccine the patient had not been tested for COVID-19.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Malaise, Pyrexia
Clinical narrative: low grade fever (100); general malaise; This is a spontaneous report from a non-contactable consumer (patient). This 62-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EL3248) via an unspecified route of administration in the left arm on 19Feb2021 at 13:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 24Feb2021 the patient experienced a low-grade fever (100) and general malaise. The events were reported as non-serious and did not require hospitalization. No treatment was provided for the events. Lab tests included body temperature of 100. The clinical outcomes of low-grade fever (100) and general malaise were unknown. It was also reported the patient had not been tested for COVID-19 since vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Mast cell degranulation present, Pruritus, Sleep disorder, Urticaria
Clinical narrative: Mast cell degranulation on back and armpits; Urticaria present; Pruritus present; awoken from sleep; This is a spontaneous report from a contactable healthcare professional (patient). This 37-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration in the left arm on 23Feb2021 at 13:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food or other products, and was not diagnosed with COVID-19 prior to vaccination. Concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 24Feb2021 at 04:00, 14.5 hours post injection, the patient was awoken from sleep and experienced mast cell degranulation on back and armpits, with urticaria present and pruritis present. Cetirizine 10 mg was taken orally. On 24Feb2021 at 04:25 the urticaria and pruritis subsided. On 24Feb2021 at 05:00, the patient went back to sleep. On 24Feb2021 at 11:00 the pruritis presented again with less intensity. The events were reported as non-serious and did not require hospitalization. The events resulted in a doctor or other healthcare professional office/clinic visit. The clinical outcomes of mast cell degranulation on back and armpits, urticaria present, pruritis present, and awoken from sleep were recovering. It was also reported that since vaccination the patient had not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, Vaccination site pain
Clinical narrative: low grade fever; tiredness; pain around injection site; This is a spontaneous report from a contactable consumer (patient). A 41-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration on an unspecified date (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On unspecified dates, the patient experienced low grade fever, tiredness, and pain around injection site. The events were reported as non-serious and did not require hospitalization. The events were treated with ibuprofen. The clinical outcomes of low-grade fever, tiredness, and pain around injection site were recovering. It was also reported that since vaccination, the patient had not been tested for COVID-19.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Rash papular, Scab
Clinical narrative: Red and purple bumps scabs covering both legs and arms; Red and purple bumps scabs covering both legs and arms; This is a spontaneous report from a contactable consumer (patient). This non-pregnant 69-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration in the left arm on 22Jan2021 at 15:45 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history, allergies to medications, food or other products, and was not diagnosed with COVID-19 prior to vaccination. The patient had no concomitant medications and had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that on 26Jan2021 at 16:00 she had red and purple bumps scabs covering both legs and arms; further reporting they looked like flea bites. She reported that they checked everywhere and there were no fleas and no bed bugs. The events were reported as non-serious and did not require hospitalization. The events resulted in a doctor or other healthcare professional office/clinic visit. Treatment was provided for the events in the form of oil on her body. The clinical outcomes of red and purple bumps scabs covering both legs and arms were not recovered. It was also reported that since vaccination, the patient had not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Paraesthesia, Paraesthesia oral
Clinical narrative: The tip of my tongue became numb and slightly tingly.; The tip of my tongue became numb and slightly tingly / around my mouth and on my cheeks became slightly tingly; around my mouth and on my cheeks became slightly tingly; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL9266), via an unspecified route of administration in the left arm on 24Feb2021 at 09:00 (at the age of 68-years-old) as a single dose for COVID-19 immunization. Medical history included arthritis, anaphylactic reaction to shellfish (patient carried an epinephrine (EPIPEN). The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included omeprazole and calcium carbonate/colecalciferol (VITAMIN D 2000). The patient did not receive any other vaccines within 4 weeks of the vaccination. The patient previously took ibuprofen and had an anaphylactic reaction (possibly) and received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EN9581) on 28Jan2021 at 09:00 (at the age of 68-years-old) in the left arm for COVID-19 immunization. On 24Feb2021 at 09:30, the tip of the patient's tongue became numb and sightly tingly. Also, around the patient's mouth and her cheeks became slightly tingly. This lasted about 45 minutes. The patient was not treated for the events. Since the vaccination, the patient was not diagnosed with COVID-19. The clinical outcome of "the tip of my tongue became numb and slightly tingly / around my mouth and on my cheeks became slightly tingly" was resolved on 24Feb2021 at 10:15.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Head discomfort, Headache, Nasopharyngitis
Clinical narrative: Severe Cold; Fever; headache; heavy head; tiredness; weakness; This is a spontaneous report from a non-contactable consumer.   A 33-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Left Arm on 23Feb2021 11:00 (Batch/Lot number was not reported) as SINGLE DOSE ( at the age of 33 years) for covid-19 immunisation.  The patient took dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization on 04Feb2021 at 09:30 in the left arm. The patient was not pregnant at the time of vaccination.   Since the vaccination, the patient has not tested for COVID-19.  Medical history included COVID-19 from an unknown date. There were no Allergies to medications, food, or other products and no other medical history.  The patient's concomitant medications were not reported.  The patient experienced severe cold on 23Feb2021 21:30 with outcome of recovering, fever on 23Feb2021 21:30 with outcome of recovering, headache on 23Feb2021 21:30 with outcome of recovering, heavy head on 23Feb2021 21:30 with outcome of recovering, tiredness on 23Feb2021 21:30 with outcome of recovering, weakness on 23Feb2021 21:30 with outcome of recovering.  No treatment was given for the events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Severe Cold; Fever; headache; heavy head; tiredness; weakness; This is a spontaneous report from a non-contactable consumer.   A 33-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Left Arm on 23Feb2021 11:00 (Batch/Lot number was not reported) as SINGLE DOSE ( at the age of 33 years) for covid-19 immunisation.  The patient took dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization on 04Feb2021 at 09:30 in the left arm. The patient was not pregnant at the time of vaccination.   Since the vaccination, the patient has not tested for COVID-19.  Medical history included COVID-19 from an unknown date. There were no Allergies to medications, food, or other products and no other medical history.  The patient's concomitant medications were not reported.  The patient experienced severe cold on 23Feb2021 21:30 with outcome of recovering, fever on 23Feb2021 21:30 with outcome of recovering, headache on 23Feb2021 21:30 with outcome of recovering, heavy head on 23Feb2021 21:30 with outcome of recovering, tiredness on 23Feb2021 21:30 with outcome of recovering, weakness on 23Feb2021 21:30 with outcome of recovering.  No treatment was given for the events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness at injection site; This is a spontaneous report from a contactable consumer (patient). A 50-year-old non-pregnant female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL3247), via an unspecified route of administration on 24Feb2021 at 08:15 (at the age of 50-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history included high blood pressure from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not tested for COVID-19 post vaccination. Concomitant medications included nebivolol hydrochloride (BYSTOLIC), hydrochlorothiazide (MANUFACTURER UNKNOWN) and birth control all from an unknown date. The patient preciously received ACE inhibitors and potentially experienced allergic reaction. The patient did not receive other vaccines within 4 weeks prior to vaccination. On 24Feb2021 at 17:00, the patient experienced soreness at the injection site. Therapeutic measures were not given for the events. The clinical outcome of the event vaccination site pain was recovering.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Vaccination site pain
Clinical narrative: Slight burning sensation at time of injection; Roughly 16 hours later onset of headache and nausea; Roughly 16 hours later onset of headache and nausea; This is a spontaneous report from a non-contactable consumer reporting for herself. A 24-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in left arm on 23Feb2021 14:30 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation.   The patient's medical history and concomitant medications were not reported.  The patient previously took bnt162b2 for covid-19 immunisation, amoxicillin and experienced known allergies: amoxicillin.    Historical vaccine information included BNT162B2 on 02Feb2021 02:30 PM, in the left arm, dose number 1 at the age of 24 years old. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 24Feb2021 06:30, the patient experienced slight burning sensation at time of injection.  Roughly 16 hours later onset of headache and nausea In Feb2021. Headache and nausea lasted roughly 14 hours in Feb2021. No treatment was received for the events. Outcome of the event was recovered in 2021. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever of 99.7; This is a spontaneous report from a contactable consumer (patient himself). A 65-year-old male patient received the second dose of bnt162b2 (formulation: solution for injection, lot number: EL9262), via intramuscularly in left arm on 24Feb2021 at 16:30 as single dose for COVID-19 immunisation. The patient's medical history included prosthetic mitral valve and previously took the first dose of bnt162b2 (Lot Number: EJ1686), via in left arm on 02Feb2021 at 11:30 as single dose for COVID-19 immunisation. The patient did not had allergy to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 25Feb2021 at 10:00, the patient experienced fever. At 14:00, the patient's body temperature was 99.7. Therapeutic measures were not received in response to the event. The outcome of the event was recovering.
Age: 73.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Cough, Oropharyngeal pain, Rhinorrhoea, Urticaria, Wheezing
Clinical narrative: Extremely itchy hives scalp, neck, ears, forearms, ankles and lower legs, abdomen/severe case of hives; Occasional wheezy cough; sore throat; runny nose; Occasional wheezy cough; This is a spontaneous report from a contactable consumer, the patient.  A 73-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number EL9269), via an unspecified route of administration, administered in Arm Left on 11Feb2021 at  15:30 (at the age of 73 years old) as SINGLE DOSE for covid-19 immunization;  chlorphenamine maleate, dextromethorphan hydrobromide, paracetamol, phenylephrine hydrochloride (ALKA SELTZER PLUS COLD &COUGH FORMULA, Lot number not provided), (reported as 'Alka Seltzer Plus Severe Cough, Mucous, Congestion') orally on 24Feb2021 at 22:00 1 DF single dose  (LIQUID GEL CAP) for sore throat runny nose and wheezy cough.   Medical history included hypothyroidism, osteoporosis, drug hypersensitivity (Allergy to: Penicillin). Concomitant medication(s) included levothyroxine (LEVOTHYROXINE); atorvastatin (ATORVASTATIN); alendronate sodium (ALENDRONATE).  No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 24Feb2021 the patient experienced occasional wheezy cough, sore throat, runny nose.  On 25Feb2021 The patient experienced extremely itchy hives scalp, neck, ears, forearms, ankles and lower legs, abdomen/severe case of hives. The clinical course as reported by patient is as follows experienced Extremely itchy hives scalp, neck, ears, forearms, ankles and lower legs, abdomen. Possibly reacted to combination of vaccine and 1 gel capsule of Alka Seltzer Plus Severe Cough, Mucous, Congestion Liquid Gel which I took for a sore throat, runny nose and cough. Have never had hives before. Have never had reaction to gel cap. Had NO reaction to vaccine first 13 days. Yesterday had a wheezy cough, runny nose, sore throat. Didn't think due to vaccine. Took gel cap about 10pm 24Feb2021. Within 2 hours had severe case of hives still present over 12 hours later, though lessened. Occasional wheezy cough. New symptom last 2 days. Not sure if linkage.  Treatment was given as a result of occasional wheezy cough, sore throat and runny nose. No Treatment was given for hives. The clinical outcome of the hives was recovering while the remaining events wheezy cough, sore throat and runny nose were not recovered.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, Vaccination site bruising, Vaccination site extravasation
Clinical narrative: I jumped when the nurse injected the vaccine and the needle pulled out.  She said I was leaking and tried to stop it with her finger.  It continued leaking and she put a bandaid on it.  I do not believe I received the full dose; I was leaking and tried to stop it with her finger. It continued leaking; bruise where the needle jerked in my arm; This is a spontaneous report received from a contactable female consumer (patient herself) of age 68-year-old (not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation; solution for injection, lot number; EL3246) via intramuscular route of administration on 21Jan2021 to right arm and second dose with lot number: EL9266 via intramuscularly on 12Feb2021 05:00 PM to left arm both as single dose for COVID-19 immunization. The patient medical history included Sjogren's and CAD. Concomitant medications were not reported. On 12Feb2021 at 05:00pm the patient reported that she experienced bruise when the needle jerked in her arm. Also said that she was jumped when the nurse injected the vaccine and observed leakage when the needle pulled out and kept band aid to stop the leakage. She believed that she doesn't received full dose. No other reaction was observed. No treatment was received for the event. Patient received other vaccines within 4 weeks prior to the covid vaccine. Patient received prescriptions and vitamins within 2 weeks of vaccination. The outcome of the event was unknown.  Ethnicity information is available and Race information is available.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Palpitations
Clinical narrative: About 3 minutes after receiving vaccine, my heart started racing . It lasted about 10 minutes. I felt slightly light headed for the first 5 minutes after, as well.; About 3 minutes after receiving vaccine, my heart started racing . It lasted about 10 minutes. I felt slightly light headed for the first 5 minutes after, as well.; This is a spontaneous report from a contactable consumer, the patient.  A 69-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EN6202), via an unspecified route of administration on 25Feb2021 at 15:00 (at the age of 69-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history included hiatal hernia, gastroesophageal reflux disease, hypertension, atrial fibrillation, dilated aorta, osteoarthritis, asthma. The patient is allergic to tea tree oil and reports an allergy to shellfish about 20 years ago. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications included rivaroxaban (XARELTO), atenolol (MANUFACTURER UNKNOWN) and pantoprazole (MANUFACTURER UNKNOWN) all from unknown dates. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient stated that on 25Feb2021, about 3 minutes after receiving vaccine, her heart started racing. It lasted about 10 minutes.  She felt slightly light headed for the first 5 minutes after, as well.T he patient did not receive any treatment for the events. The clinical outcomes of the events heart racing and lightheaded were reported as recovered on an unspecified date. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chest discomfort, Chills, Feeling abnormal
Clinical narrative: Hit with heaviness limbs; whelps all over body arms legs stomach back groin; pain in joints; felt like fire ants; chills; no energy; tightness in chest; This is a spontaneous report from a consumer reported for herself. An 61-year-old female non- pregnant is unknown female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6198), via an unspecified route of administration on Left arm on 02Feb2021 17:45 at single dose for covid-19 immunisation. Medical history included COVID-19, Congested Heart disease, and Penicillin allergy. The patient's concomitant medications were not reported. The patient experienced Hit with heaviness limbs pain in joints whelps all over body arms legs stomach back groin felt like fire ants chills no energy tightness in chest on 22Feb2021. Received Inhalers for breathing and steroids. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient diagnosed with COVID-19; Since the vaccination, the patient not been tested for COVID-19. The seriousness was reported as non-serious. The outcome of the events was "Recovering".
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Urticaria
Clinical narrative: Hit with heaviness limbs; whelps all over body arms legs stomach back groin; pain in joints; felt like fire ants; chills; no energy; tightness in chest; This is a spontaneous report from a consumer reported for herself. An 61-year-old female non- pregnant is unknown female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6198), via an unspecified route of administration on Left arm on 02Feb2021 17:45 at single dose for covid-19 immunisation. Medical history included COVID-19, Congested Heart disease, and Penicillin allergy. The patient's concomitant medications were not reported. The patient experienced Hit with heaviness limbs pain in joints whelps all over body arms legs stomach back groin felt like fire ants chills no energy tightness in chest on 22Feb2021. Received Inhalers for breathing and steroids. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient diagnosed with COVID-19; Since the vaccination, the patient not been tested for COVID-19. The seriousness was reported as non-serious. The outcome of the events was "Recovering".
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness postural, Head discomfort, Malaise, Nausea
Clinical narrative: Very nauseous; dizzy can't stand; Feeling very sick; head feels heavy; This is a spontaneous report from a contactable consumer reporting for himself. A 65-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EL9264/expiration date: not provided), via an unspecified route of administration, on 20Feb2021 at 13:00 (at the age of 65 years old) as a single dose in the left arm for COVID-19 IMMUNIZATION. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: not provided), via an unspecified route of administration, on an unknown date as a single dose for COVID-19 IMMUNIZATION. Relevant medical history and concomitant medication were not provided. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unspecified date in Feb2021, the patient was very nauseous, dizzy can't stand, feeling very sick, and head feels heavy. The patient did not require hospitalization and did not receive any treatment for these events. At the time of the report, it had been 5 days since the second dose and the outcome of the events nauseous, dizzy can' stand, feeling very sick, and head feels heavy was not recovered.  Since the vaccination, the patient had not been tested for COVID-19.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever 100.6; This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3247, Expiry date: Unknown), via an unspecified route of administration at left arm on 25Feb2021 at 08:45 AM (at the age of 39-years-old) at single dose for COVID-19 immunisation. Patient had historical vaccine received first dose of BNT162B2, lot number: EL3247 at left arm on 05Feb2021 08:45 AM for COVID-19 immunisation. Patient did not have allergies to medications, food, or other products and also did not have medical history. Concomitant medication was not reported. No other vaccines within 4 weeks prior to the COVID vaccine and No other medications within 2 weeks of vaccination. On 25Feb2021 at 09:30 PM the patient experienced fever 100.6 on. The patient underwent lab tests and procedures which included fever (Body temperature): 100.6 on 25Feb2021 at 09:30 PM. Prior to vaccination, the patient was not diagnosed with COVID-19 and also not been tested for COVID-19 after vaccination. The reporter reported seriousness criteria as non-serious. Patient did not receive any treatment for the event. The outcome of event was recovering.
Age: 39.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Fever 100.6; This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3247, Expiry date: Unknown), via an unspecified route of administration at left arm on 25Feb2021 at 08:45 AM (at the age of 39-years-old) at single dose for COVID-19 immunisation. Patient had historical vaccine received first dose of BNT162B2, lot number: EL3247 at left arm on 05Feb2021 08:45 AM for COVID-19 immunisation. Patient did not have allergies to medications, food, or other products and also did not have medical history. Concomitant medication was not reported. No other vaccines within 4 weeks prior to the COVID vaccine and No other medications within 2 weeks of vaccination. On 25Feb2021 at 09:30 PM the patient experienced fever 100.6 on. The patient underwent lab tests and procedures which included fever (Body temperature): 100.6 on 25Feb2021 at 09:30 PM. Prior to vaccination, the patient was not diagnosed with COVID-19 and also not been tested for COVID-19 after vaccination. The reporter reported seriousness criteria as non-serious. Patient did not receive any treatment for the event. The outcome of event was recovering.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea
Clinical narrative: Nausea; fatigue; chills; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EL3247, first dose) solution for injection intramuscular in the left arm on 25Feb2021 at 10:00 (at the age of 43-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. There was no medical history. Concomitant medications included daily vitamins and birth control pill. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 25Feb2021 at 16:00, the patient experienced nausea, fatigue, chills. No treatment was provided for the events nausea, fatigue, chills. The outcome of the events nausea, fatigue, chills was recovered on 25Feb2021. Since the vaccination, the patient has not been tested for COVID-19.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore injection site arm; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: Unknown) via an unspecified route of administration on an unspecified date (at the age of 39-years-old) as a single dose for COVID-19 immunization. The patient had no medical history and no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medication included escitalopram oxalate (LEXAPRO). On 26Feb2021, the patient experienced sore injection site arm. The patient was not treated for sore injection site arm. The clinical outcome of sore injection site arm was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Diarrhoea
Clinical narrative: stomach discomfort; diarrhea; This is a spontaneous report from a contactable consumer. A 53-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation:Solution for injection,Lot Number: EL3247) via an unspecified route of administration in Arm Right on 25Feb2021 14:15, as a single dose for COVID-19 immunisation. Medical history included asthma, bronchiectasis, anxiety. No allergies to medications, food, or other products. Concomitant medication included Propranolol, multivitamin, B complex, D3, Omega 3. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 26Feb2021 05:15, the patient experienced stomach discomfort (abdominal discomfort) and diarrhea. No treatment received for the adverse events. Serious reported as no. The outcome of the events was not recovered.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Feeling of body temperature change, Heart rate, Heart rate increased, Lethargy
Clinical narrative: migraine at rhe base of my Head; My heart rate rose to around 133 just laying down; extremely nauseous; inability to control temperature regulation; stomach began to have a really intense stabbing pains; Not the worst pain I have experienced but definitely not pleasent; lethargic; getting extremely cold and then hot within a matter of minutes; Her ribs and lungs hurt; Her ribs and lungs hurt; This is a spontaneous report from a contactable consumer (patient). An 18-year-old female patient received second dose bnt162b2 (Pfizer COVID 19 vaccine), via an unspecified route of administration, administered in Arm Left on 24Feb2021 10:15 (Lot Number: EN6202) as single dose for COVID-19 immunisation. Medical history included known allergies to Red dye, postural orthostatic tachycardia syndrome (POTS), heart murmur, Wilkies syndrome. The patient was not pregnant. There were no concomitant medications. The patient did not take other medications in two weeks. The patient previously took Excedrin and experienced allergies. The patient previously received first dose bnt162b2 (Pfizer COVID 19 vaccine), via an unspecified route of administration, administered in Arm Left on 03Feb2021 09:45 AM (Lot Number: EL9269) for COVID-19 immunisation. The patient did not receive other vaccine in four weeks. On 24Feb2021 at around 7:00pm she started getting a migraine at the base of her head. She then was lethargic, and became extremely nauseous. She started getting extremely cold and then hot within a matter of minutes (inability to control temperature regulation). Her heart rate rose to around 133 just laying down. Her ribs and lungs hurt. And her stomach began to have a really intense stabbing pains. At one point it felt as if she could feel every cell in her body if that makes sense. Not the worst pain she had experienced but definitely not pleasant. On a scale of 1 to 10 (10 being run over by a car and 1 being a paper cut) she would say it was a 5-6. The patient did not receive treatment for the events. Facility type vaccine was facility. The patient did not have COVID prior vaccination and did not have COVID test post vaccination. The outcome of the events was recovered on an unspecified date.